NCT04932135View on ClinicalTrials.gov

Resting Heart Rate Monitoring for Optimized Treatment and Surveillance of Hyperthyroidism

CompletedOBSERVATIONAL
Enrollment

35

Participants

Timeline

Start Date

June 8, 2021

Primary Completion Date

March 21, 2023

Study Completion Date

October 30, 2023

Conditions
HyperthyroidismGraves Disease
Interventions
DIAGNOSTIC_TEST

Continuous heart rate monitoring

Continuous heart rate monitoring with a wrist worn fitnesstracker

Trial Locations (1)

4031

University Hospital Basel, Basel

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER